Laboratorios Farmaceuticos Rovi, S.A. (OTCMKTS:LABFF) Short Interest Update

Laboratorios Farmaceuticos Rovi, S.A. (OTCMKTS:LABFF) was the target of a large decrease in short interest in November. As of November 30th, there was short interest totalling 4,300 shares, a decrease of 23.2% from the November 15th total of 5,600 shares. Based on an average daily trading volume, of 100 shares, the short-interest ratio is currently 43.0 days.

Laboratorios Farmaceuticos Rovi Price Performance

Shares of OTCMKTS LABFF remained flat at C$65.86 during mid-day trading on Monday. The business has a 50 day moving average price of C$83.68 and a 200 day moving average price of C$87.43. Laboratorios Farmaceuticos Rovi has a fifty-two week low of C$65.86 and a fifty-two week high of C$65.86.

Laboratorios Farmaceuticos Rovi Company Profile

Laboratorios Farmaceuticos Rovi, SA engages in the research, development, manufacture, and marketing of pharmaceutical products in Spain and internationally. The company provides products for cardiology, osteoarticular/women's health, anesthesia /pain, diagnostic imaging contrast agents, central nervous system, urology, endocrinology, respiratory, and primary healthcare areas.